Corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. - Lin Y; Gu Q; Lu S; Pan Z; Yang Z; Li Y; Yang S; Lv Y; Zheng Z; Sun G; Gou F; Xu C; et al. (The Journal of clinical investigation, 2025)